Background & Aims Celiac disease is a major public health problem worldwide. Although
initially it was reported from countries with predominant Caucasian populations, it now has …

Celiac disease (CD) is a complex immune-related disease with a very strong genetic
component. Multiple genetic findings over the last decade have added to the already known …

Background & Aims A higher proportion of female vs male patients receive a diagnosis of
celiac disease. Little is known about sex-based differences in the prevalence of celiac …

Up until the 1960s and 1970s, diarrhea, malabsorption syndrome, and failure to thrive were
the presenting symptoms and signs of celiac disease (CD) in young infants; however this …

Celiac disease is one of the commonest life-long disorders worldwide, with a prevalence
mostly ranging between 0.7 and 2.9% in the general population and a higher frequency in …

Celiac disease (CD) is triggered by both genetic and environmental factors. More than 1% of
the world's population is affected by CD. In recent years, studies have confirmed a …

Background: Recently, POCTs for CD have been developed and are commercially
available. Studies have reported significant variability in their sensitivity (70% to 100%) and …

Celiac disease is a global disease requiring genetic susceptibility and gluten exposure to
trigger immune‐mediated enteropathy. The effect of the degree of gluten‐containing grain …

Coeliac disease (CD) is an immune-mediated inflammatory disease triggered by dietary
gluten and related proteins in genetically predisposed individuals. Point-of-care (POC) …

Immunoglobulin A (IgA) is the principal antibody in secretions that bathe the gastrointestinal
and respiratory mucosal surfaces and acts as an important first line of defense against …